全文获取类型
收费全文 | 59803篇 |
免费 | 6190篇 |
国内免费 | 4213篇 |
专业分类
耳鼻咽喉 | 647篇 |
儿科学 | 638篇 |
妇产科学 | 492篇 |
基础医学 | 5415篇 |
口腔科学 | 1112篇 |
临床医学 | 7327篇 |
内科学 | 6925篇 |
皮肤病学 | 516篇 |
神经病学 | 2698篇 |
特种医学 | 2402篇 |
外国民族医学 | 24篇 |
外科学 | 6460篇 |
综合类 | 13939篇 |
现状与发展 | 15篇 |
一般理论 | 3篇 |
预防医学 | 5388篇 |
眼科学 | 1221篇 |
药学 | 6627篇 |
63篇 | |
中国医学 | 3974篇 |
肿瘤学 | 4320篇 |
出版年
2024年 | 232篇 |
2023年 | 891篇 |
2022年 | 2503篇 |
2021年 | 2882篇 |
2020年 | 2223篇 |
2019年 | 1551篇 |
2018年 | 1821篇 |
2017年 | 1916篇 |
2016年 | 1718篇 |
2015年 | 2791篇 |
2014年 | 3551篇 |
2013年 | 3690篇 |
2012年 | 5288篇 |
2011年 | 5803篇 |
2010年 | 4402篇 |
2009年 | 3780篇 |
2008年 | 4128篇 |
2007年 | 3969篇 |
2006年 | 3602篇 |
2005年 | 3118篇 |
2004年 | 2054篇 |
2003年 | 1702篇 |
2002年 | 1314篇 |
2001年 | 1098篇 |
2000年 | 934篇 |
1999年 | 653篇 |
1998年 | 397篇 |
1997年 | 363篇 |
1996年 | 259篇 |
1995年 | 262篇 |
1994年 | 173篇 |
1993年 | 137篇 |
1992年 | 150篇 |
1991年 | 145篇 |
1990年 | 115篇 |
1989年 | 71篇 |
1988年 | 94篇 |
1987年 | 85篇 |
1986年 | 76篇 |
1985年 | 48篇 |
1984年 | 35篇 |
1983年 | 15篇 |
1982年 | 16篇 |
1981年 | 16篇 |
1980年 | 9篇 |
1979年 | 16篇 |
1978年 | 15篇 |
1974年 | 10篇 |
1958年 | 11篇 |
1954年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Yong Tao Byunghak Kang Daniel A. Petkovich Yuba R. Bhandari Julie In Genevieve Stein-OBrien Xiangqian Kong Wenbing Xie Nicholas Zachos Shinji Maegawa Himani Vaidya Stephen Brown Ray-Whay Chiu Yen Xiaojian Shao Jai Thakor Zhihao Lu Yi Cai Yuezheng Zhang Hariharan Easwaran 《Cancer cell》2019,35(2):315-328.e6
994.
目的:观察小鼠肾脏缺血再灌注损伤(IR)后不同时间点的血清及肾组织中白细胞介素-17(IL-17)的变化情况。方法:将C57BL/6雄性小鼠随机分为两组。假手术组(n=20)小鼠仅暴露腹腔游离肾蒂,30分钟后关闭腹腔;IR组(n=20)采用100g压力无创血管夹夹闭双侧肾蒂,30分钟后去除,恢复血流。于肾脏IR手术再灌注后3、6、12、24小时收集小鼠血浆及肾脏标本,用全自动生化仪分析血清中肌酐(SCr)与尿素氮(BUN)含量;用HE染色法观察小鼠肾脏组织病理变化;应用酶联免疫吸附法(ELISA)检测不同时间点小鼠血清及肾脏组织中IL-17的含量。结果:肾脏IR诱导小鼠血清BUN、SCr水平显著增高,肾小管坏死率也显著增加,均于IR后24小时达高峰,与假手术组小鼠3、6、12及24小时同时间点相比较,差异有统计学意义(P0.01);小鼠血清及肾组织中IL-17含量也随病情进展表现出升高趋势,IR后24小时达顶峰,与假手术组同时间点相比,差异均具有统计学意义(P0.01)。结论:小鼠肾IR后血清及肾组织中IL-17表达明显增加,大量IL-17表达与肾IR后炎症反应的发生密切相关。IL-17的大量表达可能对小鼠肾脏功能损伤及病理改变有诱导或促进作用。 相似文献
995.
Yue-Chao Ding Wei Yu Chao Ma Qian Wang Chang-Shan Huang Tao Huang 《International journal of clinical and experimental pathology》2014,7(11):8065-8070
Introduction: Dysregulation of long non-coding RNAs (lncRNAs) plays critical roles in tumor progression. lncRNA LOC285194 was previously shown to be correlated with aggressive clinicopathological features and poor prognosis in several cancers. The aim of this study was to investigate relationship between LOC285194 expression and clinical outcomes in human pancreatic ductal adenocarcinoma (PDAC). Methods: Quantitative real-time PCR (qRT-PCR) assay was performed to detect the expression of lncRNA LOC285194 in human PDAC cells and tissue samples. The association of LOC285194 expression with clinicopathologic features was analyzed. Kaplan-Meier analyses were used to assess survival of patients. Univariate and multivariate analyses were performed using the Cox proportional hazards model to analyze the prognostic significance of LOC285194 expression. Results: Our data showed that the relative level of LOC285194 in PDAC cells was significantly lower than that in normal human pancreatic duct epithelial cell line. Also, the expression of LOC285194 in PDAC tissues was significantly lower than that in adjacent non-tumor tissues. By statistical analyses, low LOC285194 expression was observed to be closely correlated with clinical stage, lymphnode metastasis and liver metastasis. Kaplan-Meier survival analysis revealed that patients with low LOC285194 expression had a poor overall survival compared with the high LOC285194 group (P < 0.05). Univariate and multivariate analyses showed that low LOC285194 expression was an independent poor prognostic factor for PDAC patients. Conclusions: Our data provided the first evidence that reduced LOC285194 in PDAC tissues was correlated with tumor progression, and lncRNA LOC285194 might be a potential molecular biomarker for predicting the prognosis of patients. 相似文献
996.
997.
998.
999.
Tao Lin Junbin Liu Shuhua Yang Xianzhe Liu Xiaobo Feng Dehao Fu 《Indian Journal of Orthopaedics》2016,50(4):406-413
Background:There has been a recent increase in the number of patients suffering from bone and joint diseases, as a consequence of corticosteroids administration. There are more patients treated with low dose of GCs under long-term conditions in clinical, such as effect of GCs on Rheumatoid arthritis, Crohn''s disease and Asthma patients. Hence, it was difficult for doctor to determine which problem occur first – OP or ON; however, there was no clinical report previously in the literature, and there was no effective animal model of OP and ON about low dose GCs. This study was conducted to develop rabbit models of glucocorticoid (GC)-induced femoral head ON and OP and to investigate the temporal relationship between the occurrence of the two events following administration of glucocorticoids.Results:At 4 weeks in the GC group, the BMD of the femur reduced 33% and 22% in the femoral head and shaft; there was irregular intermediate to high T2-weighted images signals; μ-CT showed microfractures and cystic changes in the femoral head and L4 at 4 weeks. At 8 weeks in the GC group, the classical “line-like sign” indicating ON of the femoral head was observed in 64.3% of the rabbits.Conclusion:A rabbit model of GC-induced OP and ON was developed by repetitive injection with small doses of GCs in the gluteal region. OP was observed at 4 weeks while ON developed at 8 weeks and followed a clear temporal pattern. 相似文献